Matʼoška V - Search Results

1

Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors.

Tomek A, Matʼoška V, Frýdmanová A, Magerová H, Šrámek M, Paulasova-Schwabová J, Růžičková T, Janský P, Šarbochová I, Hadačová I, Kaplan V, Lacinová Z, Táborský L, Serebruany V. Tomek A, et al. Am J Ther. 2018 Mar/Apr;25(2):e202-e212. doi: 10.1097/MJT.0000000000000416. Am J Ther. 2018. PMID: 29509167

2

Fluorescent multiplex PCR--fast method for autosomal dominant spinocerebellar ataxias screening.

Bauer PO, Kotliarova SE, Matoska V, Musova Z, Hedvicakova P, Boday A, Tomek A, Nukina N, Goetz P. Bauer PO, et al. Genetika. 2005 Jun;41(6):830-7. Genetika. 2005. PMID: 16080609

3

[Application of warfarin pharmacogenetics].

Tomek A, Mat'oska V, Kumstýrfová T, Táborský L. Tomek A, et al. Vnitr Lek. 2009 Jun;55(6):565-9. Vnitr Lek. 2009. PMID: 19662888 Review. Czech.

4

Optimization of anticoagulation with warfarin for stroke prevention: pharmacogenetic considerations.

Tomek A, Matoska V, Eisert C, Serebruany VL. Tomek A, et al. Am J Ther. 2011 May;18(3):e55-66. doi: 10.1097/MJT.0b013e3181cea0cd. Am J Ther. 2011. PMID: 20335792 Review.

5

The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes.

Tomek A, Maťoška V, Kolářová T, Neumann J, Srámek M, Sarbochová I, Táborský L, Bojar M, Goetz P, Serebruany VL. Tomek A, et al. Cardiology. 2013;125(3):182-91. doi: 10.1159/000350407. Epub 2013 Jun 12. Cardiology. 2013. PMID: 23774101

6

The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.

Laczó J, Andel R, Vyhnalek M, Matoska V, Kaplan V, Nedelska Z, Lerch O, Gazova I, Moffat SD, Hort J. Laczó J, et al. Neurobiol Aging. 2015 Jun;36(6):2024-33. doi: 10.1016/j.neurobiolaging.2015.03.004. Epub 2015 Mar 16. Neurobiol Aging. 2015. PMID: 25862420

7

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ.

Libertinova J, Meluzinova E, Tomek A, Horakova D, Kovarova I, Matoska V, Kumstyrova S, Zajac M, Hyncicova E, Liskova P, Houzvickova E, Martinkovic L, Bojar M, Havrdova E, Marusic P. Libertinova J, et al. PLoS One. 2017 Jan 12;12(1):e0169957. doi: 10.1371/journal.pone.0169957. eCollection 2017. PLoS One. 2017. PMID: 28081207 Free PMC article. Clinical Trial.

8

MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients.

Libertinova J, Meluzinova E, Matoska V, Zajac M, Kovarova I, Havrdova E, Horakova D, Tomek A, Marusic P, Bojar M. Libertinova J, et al. Brain Behav. 2017 Feb 9;7(3):e00644. doi: 10.1002/brb3.644. eCollection 2017 Mar. Brain Behav. 2017. PMID: 28293479 Free PMC article.

9

Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients - a randomized, prospective study.

Ruzickova T, Sramek M, Kaplan V, Kumstyrova S, Lacinova Z, Jansky P, Magerova H, Sarbochova I, Schwabova JP, Matoska V, Tomek A. Ruzickova T, et al. Pharmacogenomics J. 2019 Oct;19(5):446-454. doi: 10.1038/s41397-019-0066-4. Epub 2019 Jan 16. Pharmacogenomics J. 2019. PMID: 30647445 Clinical Trial.

10

Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.

Cechova K, Andel R, Angelucci F, Chmatalova Z, Markova H, Laczó J, Vyhnalek M, Matoska V, Kaplan V, Nedelska Z, Ward DD, Hort J. Cechova K, et al. J Alzheimers Dis. 2020;73(1):247-257. doi: 10.3233/JAD-190464. J Alzheimers Dis. 2020. PMID: 31771052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters